IP Library Granted Patent US 7,727,548
Granted Patent B2
US 7,727,548 · App. 10/203,687 · Granted Jun 1, 2010

Rapidly disintegrable tablet containing polyvinyl alcohol

Assignee: Eisai R&D Management Co., Ltd.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 7,727,548
App. No.
10/203,687
Granted
Jun 1, 2010
Kind
B2
Abstract

The present invention provides a quickly disintegrating tablet which has quick disintegrability and solubility in an oral cavity, and does not have uncomfortable tastes such as bitterness, has a small variation of a tablet physical property even in storage under a humidifying condition, and has substantially no change in a medicine content in the tablet and tablet appearance and which is superior in stability; and a manufacturing method of the tablet. That is, it provides: a quickly disintegrating tablet which is prepared by blending a medicine with a saccharide and polyvinyl alcohol, which has small variations of tablet weight, tablet hardness, tablet diameter and tablet thickness, and which is superior in medicine stability in the tablet; and a manufacturing method of the tablet.

Claims (8)

1. A quickly disintegrating tablet comprising a medicine, mannitol and polyvinyl alcohol,

wherein the medicine is famotidine, midodrine hydrochloride, brotizolam or donepezil hydrochloride,

said quickly disintegrating tablet is compressed,

said tablet quickly disintegrates in an oral cavity,

a compounding ratio of the mannitol is 0.8 part by weight or more to one part by weight of the tablet, and

a compounding ratio of the polyvinyl alcohol is 0.0001 to 0.1 parts by weight to one part by weight of the tablet.

2. The quickly disintegrating tablet according to claim 1 , wherein the medicine is donepezil hydrochloride.

3. A method of administering a medicine, said method comprising orally administering a medicine in the form of the quickly disintegrating tablet of claim 1 to a patient in need thereof.

Assignments (2)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Jun 29, 2007
From: EISAI CO., LTD.
To: EISAI R&D MANAGEMENT CO., LTD.
Reel/Frame 019500/0673 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 13, 2002
From: MORITA, YUTAKA; YASUI, MASANOBU; OHWAKI, TAKAYUKI; TSUSHIMA, YUKI
To: EISAI CO., LTD.
Reel/Frame 013356/0150 →
Priority Claims (1)
JP 2000-56176 · Mar 1, 2000 · national
Continuity (1)
Related Publication 20030086967A1 · May 8, 2003